Dexcom’s G6 continuous glucose monitoring system will now be available at no cost for qualifying veterans through all U.S. Department of Veterans Affairs pharmacies, the company announced Tuesday. To ...
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the publication of a ...
EDINBURGH, Oct. 2, 2020 /PRNewswire/ --This long-term health economic analysis was performed to establish the cost-effectiveness for funding of the Dexcom G6 versus fingerstick testing. It examines UK ...
The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
Wider use of the Dexcom G6 real-time continuous glucose monitoring (RT-CGM) system in the United Kingdom would be cost-effective in the long term, new research suggests. The analysis was published in ...
Benchmark on Monday started coverage of Dexcom with a Buy rating and a $77 price target, arguing the medical technology company is on track to expand margins meaningfully over the next two years as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results